Earnings · China A-shares
Zhejiang Orient Gene Biotech Co., Ltd. Class A (688298) earnings
Zhejiang Orient Gene Biotech Co., Ltd. Class A published its Q3 report on 2026-10-28: net profit -39.82% year on year, -35.78% excluding one-off items. Wave Radar's earnings-quality score is 59 of 100 (Questionable). The stock moved -5.78% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-28
- Period end
- 2026-09-30
- Net profit YoY
- -39.82%
- Excl. one-offs YoY
- -35.78%
- Result
- Bad / loss
- Quality score
- 59
- Quality
- Questionable
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -4.20% | — |
| 3 days | -5.78% | — |
| 7 days | +0.76% | — |
| 14 days | -7.63% | — |
Report history
Over the last 8 reports, net profit grew year on year in 2 of them. The stock rose in the 3 trading days after 3 of 6 reports (average +0.86%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-29 | -¥297.30M | -39.82% | -35.78% | +6.81% | -1.55 | -5.10% | -5.78% | — | — |
| 2026 interim report | 2026-08-29 | -¥222.23M | -36.26% | -29.23% | +15.15% | -1.16 | -3.78% | -2.94% | -9.17% | +0.16% |
| 2026 Q1 report | 2026-04-29 | -¥93.84M | +18.72% | +10.62% | +33.50% | -0.49 | -1.58% | +4.11% | -11.60% | -12.54% |
| 2025 annual report | 2026-04-29 | -¥573.60M | -8.43% | -4.58% | +14.43% | -2.98 | -9.06% | +4.11% | -11.60% | -12.54% |
| 2025 Q3 report | 2025-10-31 | -¥212.63M | +18.89% | +33.71% | +2.16% | -1.10 | -3.26% | +5.55% | -2.29% | +2.39% |
| 2025 interim report | 2025-08-29 | -¥163.10M | -7.58% | +11.18% | -3.62% | -0.84 | -2.49% | -1.06% | -9.14% | -10.42% |
| 2025 Q1 report | 2025-04-30 | -¥115.45M | -71.41% | -8.19% | +4.94% | -0.57 | -1.75% | +5.30% | +18.57% | +15.39% |
| 2024 annual report | 2025-04-30 | -¥529.02M | -33.06% | -32.60% | +0.95% | -2.69 | -7.54% | +5.30% | +18.57% | +15.39% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.